Lupin complete successful UK MHRA inspection

We are committed to maintaining truly global quality standards at all our manufacturing facilities- Lupin

229
Documents of medical store
Picture: Pixabay

Lupin complete successful UK MHRA inspection

Lupin has announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK), at its three manufacturing units in Pithampur (India).

Inspection

The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020. Commenting on the positive outcome, Nilesh Gupta, Managing Director, Lupin, said, “We are committed to maintaining truly global quality standards at all our manufacturing facilities.

Also read: FDA approves Dr Reddy’s NDA for migraine drug

The successful close out of the inspection at Pithampur, and release of the inspection report by UK MHRA further bolsters our confidence in our quality standards and manufacturing processes.”

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.